Follicle-stimulating hormone (Fsh) is thought to act early in the process of spermatogenesis; however, its action in fish has not yet been clearly established. In the present work, we analyzed the effects of recombinant Fsh in sea bass (Dicentrarchus labrax) spermatogenesis according to two different approaches: direct injection of recombinant single-chain Fsh hormone (scFSH) and injection of scFSH coding sequence. Both approaches were efficient in increasing plasma Fsh at 7 and 15 days, respectively, after injection. The Fsh increment caused a significant increase in plasma 11-ketotestosterone levels and induced dramatic changes at the testicular level. Fsh-treated groups showed an increase in germ cell proliferation at Day 7, and cysts of spermatocytes and spermatids were observed at the end of the experiment. After treatment with Fsh, a suppression in amh transcripts and an increase of lhr transcripts were detected at Day 7 and Day 15, respectively, and an increment in fshr expression became evident at Day 23. These results show that Fsh initiates germ cell proliferation, triggering spermatogenesis in sea bass via androgen production and regulation of spermatogenesis-related genes.
INTRODUCTION
The role of gonadotropins in the reproductive process of fish is gradually being elucidated; however, the specific roles of follicle-stimulating hormone (Fsh) and luteinizing hormone (Lh) have not yet been fully defined. It is generally accepted that Fsh may act on the early events of fish gametogenesis, whereas Lh may act on the final events of this process. In mammals, separating the specific effects of FSH and LH on germinal cell development is a complicated matter, because the final action of both hormones takes place in Sertoli cells, where FSH acts directly via the FSH receptor (FSHR) and LH stimulates androgen production via Leydig cells [1] . Recent studies in fish have shown that fshr is expressed in Leydig cells in addition to Sertoli cells [2, 3] . Therefore, Fsh may act directly on Leydig cells and stimulate steroid production in fish, unlike in mammals.
Previous observations showed that Sertoli cells do not increase in number in mice lacking FSHR [4] . As a consequence, the total germ cell number and the number of germ cells associated with each Sertoli cell also failed to increase. This situation caused a reduction in testes size and sperm quality; however, the mice remained fertile, providing evidence that FSH is not essential for mammalian spermatogenesis. Furthermore, FSH suppression in human and rat males [5] did not affect germ cell proliferation, with the function of this hormone being the prevention of spermatogonial apoptosis. On the other hand, in newts, FSH has been described as essential for completion of the last spermatogonial mitosis [6] . In fish, both in vivo and in vitro studies [7] [8] [9] [10] support the proliferative effect of recombinant Fsh on spermatogonia cells. Thus, complete spermatogenesis was attained in Japanese eel after in vitro treatment with recombinant Fsh [7, 8] , and sperm production was attained when recombinant Fsh was administered in vivo to the Japanese eel and goldfish [9, 10] .
In vitro experiments with Japanese eel had proven that in the absence of Fsh, the addition of 11-ketotestosterone (11-KT) can stimulate the entire process of spermatogenesis, most likely via the activation of Sertoli cells [8, 11, 12] . These results provided evidence that the main function of Fsh in Japanese eel spermatogenesis is to stimulate androgen production [12] . Hence, it is not yet clear whether Fsh is an essential hormone for gametogenesis or whether its functions could be substituted by the activity of steroid hormones.
In vitro studies carried out on zebrafish and Japanese eel demonstrated that the anti-Müllerian hormone (Amh) restrains the onset of the spermatogenic process by inhibiting androgen synthesis, the expression of which is regulated by Fsh [13, 14] . In the present study, the action of Fsh on Amh expression or androgens in sea bass (Dicentrarchus labrax) is assessed in vivo.
Purified and recombinant gonadotropins have been used for reproductive research in a wide variety of species. The disadvantage of this approach is that it requires frequent doses due to hormone degradation. In addition, recombinant protein production has several drawbacks, including the need for high levels of protein production, a correct posttranslational modification to ensure its functionality, and an easy method of purification. In mammals, the use of somatic gene transfer through plasmid vectors to deliver a recombinant protein is becoming a real alternative because of its simplicity and low cost [15] . Our previous studies using plasmid DNA injections in sea bass skeletal muscle have demonstrated the ability of this tissue to incorporate and express the injected gene [16] . Moreover, injection of a plasmid encoding a single-chain Lh resulted in the production of the blood-secreted recombinant Lh, which had physiological effects on milt production in adult sea bass [17] .
To clarify the ability of Fsh in promoting spermatogenesis, we administered intramuscular injections of recombinant single-chain Fsh (scFSH) or Fsh coding sequence to juvenile males. Once an increase of Fsh plasma levels was confirmed, its in vivo activity was investigated by the study of testis development, the evaluation of 11-KT plasma levels, and the examination of changes in the expression of genes involved with the process of spermatogenesis. We evaluated changes in the expression patterns of the gonadotropin receptor genes fshr and lhr to assess whether the former was within the scope of Fsh activity and the latter was a marker of late spermatogenesis. Transcripts of Amh (amh), also defined as a spermatogenesis-preventing substance [14] , and of synaptonemal complex protein 3 (scp3), a marker of meiosis, were also quantified. Taken together, the results show that an expression vector encoding an scFSH could be an efficient method to trigger testicular recrudescence, supporting this methodology as an instrument for reproductive research and as an aquaculture technology to remedy captive broodstock dysfunctions.
MATERIALS AND METHODS

Animals
Ten-month-old prepubertal European male sea bass (weight, 66.8 6 14.7 g [mean 6 SEM]) purchased from Aquanord were distributed among five separate circular fiberglass tanks with a capacity of 500 L and fed a commercial diet (Proaqua Nutrición, S.A.; Palencia, Spain) once a day. Fish were individually weighed and tagged (PIT tags; Fish Eagle) at the abdominal cavity. The experiment was performed during the months of November and December under natural photoperiod conditions (408N, 08E). Five experimental groups were set up, with two groups treated using recombinant Fsh and three control groups. Treated groups were injected with recombinant scFSH or with the pcDNA3-scFsh plasmid (pscFSH) containing the scFsh gene under the control of a CMV promoter [15] . The control groups consisted of nontreated fish (CONTROL), fish injected with a control plasmid (pcDNA3), or fish injected with Chinese Hamster Ovary cell-conditioned culture medium (CHO). The last two groups served as controls for the pscFSH-and scFSH-treated group, respectively. The seawater temperature was maintained in a natural range for scFSH and CHO groups (12-148C) and at 178C for the CONTROL, pcDNA3, and pscFSH groups to allow plasmid uptake by the muscle cells.
Production of Recombinant Sea Bass Fsh Gonadotropin
Recombinant sea bass scFsh is produced by a stable clone of CHO cells containing the pcDNA3-scFsh construct (CHO-scFsh) [18] . Hormone production was performed as described by Schatz et al. [19] . Accordingly, CHO-scFsh cells were grown in 75-cm 2 flasks to 80%-90% confluence with Dulbecco modified Eagle medium (DMEM; Invitrogen Corp.) supplemented with 100 U/ ml of penicillin, 100 lg/ml of streptomycin, and 5% fetal bovine serum (FBS). The medium was then replaced by DMEM without FBS but containing 100 U/ ml of penicillin and 100 lg/ml of streptomycin and maintained in a humidified atmosphere of 5% CO 2 at 258C for 9 days. The cultured medium was then collected and concentrated using 30-kDa centrifugal filter devices (Centricon Plus-20; Millipore) and subsequently quantified. CHO wild-type cells were grown and treated as described above for scFsh production. Their concentrated medium was injected in the CHO group to control the effect of CHO cellproducing factors.
Plasmid and Hormone Injections
Fish were injected intramuscularly to a depth of 4-6 mm in the left epaxial muscle anterior to the dorsal fin using an insulin syringe and a 26.5-gauge needle. Before treatment, fish were anesthetized in ethylene glycol-monophenyl ether (0.5 ml/L water). The pscFSH and pcDNA3 groups received two injections, on Days 0 and 3, with 75 lg/fish of plasmid diluted in a final volume of 100 ll of PBS. Plasmids were prepared using an anion-exchange resin (Plasmid Mega Kit; Qiagen). To ensure a correct integration of the plasmids, four electroporation pulses of 90 V/cm and 20 msec, using needle array-type electrodes (2-Needle Array Model 531; BTX), were applied around the area of injection to all fish immediately after DNA injection. The scFSH and CHO groups also received two injections on Days 0 and 3. The scFSH group received 0.5 lg of scFsh (equivalent to 27 ll of the concentrated medium containing scFsh) in a final volume of 100 ll of PBS, whereas the CHO group was treated with 27 ll of concentrated conditioned CHO medium in a final volume of 100 ll of PBS. Seven noninjected fish were sampled at the time of first injection and served as an initial control.
Animals were killed in accordance with the Spanish (Royal Decree Act 53/ 2013) and European (2010/63EU) legislations concerning the protection of animals used for experimentation. The protocol used to euthanize the animals was approved by the Welfare Committee of the IATS (Number of Register 09-0201) supervised by the Ministry of Rural and Marine Environment. All steps were taken to reduce suffering of the animals.
Sampling Procedures
The experiments lasted 15 days for hormone-injected fish (scFSH and CHO groups) and 23 days for DNA-injected fish (pcDNA3 and pscFSH groups) and the CONTROL group. Presumably, as observed for single-chain Lh [17] , the bioavailability of scFsh in the bloodstream would take longer in the animals injected with plasmid than in those directly injected with the hormone; therefore, the experiment was prolonged one more week in the case of the plasmid-treated groups. Fish were sampled weekly, after anesthesia with ethylene glycol-monophenyl ether (0.5 ml/L water). Blood was withdrawn by caudal puncture, and plasma was obtained by centrifugation (2500 3 g, 30 min, 48C) and stored at À208C until the time of hormone analysis. At Days 7, 15, and 23 after the first injection, 10 fish were killed per group, and their gonads were dissected. Two hours before euthanization, five fish were injected intraperitoneally with 50 mg/kg of 5-bromo-2 0 -deoxyuridine (BrdU; Sigma) for immunodetection of gonad cell proliferation. Aliquots of the gonads were fixed in a solution of 4% formaldehyde and 1% glutaraldehyde-buffered saline [20] for histological studies or in 4% paraformaldehyde and 10% picric acid for immunocytochemical studies. A second aliquot was stored at À808C for RNA extraction.
Hormone Analysis
Plasma levels of Fsh were determined using a HEK293 cell line-based bioassay as described previously [18] . Briefly, cells of asbsFSHR/pCRE-LUC HEK293 stable clone were cultured in 96-well, flat, white-walled plates (Corning) and challenged for 7 h with fish plasma diluted 1:25 in Advanced DMEM (Gibco). Medium with plasma was then removed, and levels of luciferase activity were directly measured on the plates using the Tropix LucScreen kit (Applied Biosystems), according to the manufacturer's instructions, and the Ultra Evolution (Tecan) detection platform. Luciferase activity was expressed as relative light units. The same bioassay was used to calibrate and measure the activity of the concentrated medium containing scFsh, using known quantities of purified native sea bass Fsh as a standard curve. Levels of 11-KT were analyzed by enzyme immunoassay as described previously [21] .
RNA Isolation and Reverse Transcription for Real-Time Quantitative PCR Assays
Total RNA was isolated from the frozen tissue using TRI Reagent (Molecular Research Center) according to the manufacturer's protocol. RNA integrity, purity, and concentration were determined after electrophoresis in an agarose gel with measurement of absorbance at 260/280 nm (GeneQuant; Pharmacia Biotech). The cDNA synthesis was performed using SuperScript II Reverse Transcriptase (Invitrogen Corp.) by priming 1 lg of RNA with 100 ng of random hexamers and following the supplier's instructions.
Gene expression was quantified using these cDNAs and real-time quantitative RT-PCR. All samples were run in triplicate on an iCycler iQ (Bio-Rad Laboratories, Inc.), using 96-well optical plates, default settings, and ABgene ABsolute qPCR Mix (ABgene). For each 25 ll of PCR reaction, 1 ll of RT reaction was mixed with the corresponding amount of TaqMan primers and probes, except in the case of 18s rRNA, in which the template was 1 ll of a 1:10 dilution. Standard curves were prepared for target genes and the endogenous reference, 18s, using 10-fold serial dilutions of plasmids containing each gene. Correlation coefficients of the standard curves ranged from 0.99 to 1.00, with a PCR efficiency of between 89%-97%. The quantification of the sea bass target genes fshr, lhr, amh, and the housekeeping gene 18s was performed as described previously [22, 23] .
A cDNA fragment from the sea bass scp3 gene was amplified by PCR using 1 ll of testicular cDNA and the specific scp3 primers (forward, 5 0 -AACTCCGATAGTGGAAAAGTTGG-3 0 ; reverse, 5 0 -AACAGGCTAGAA CAGCATGGAC-3 0 ), the sequences of which were taken from the sea bass genome database (Kuhl and Reinhardt, unpublished). Touchdown PCR conditions were an initial denaturation step at 948C for 2 min followed by 20 MAZÓ N ET AL.
cycles of 948C for 30 sec and annealing at 668C for 30 sec, decreasing 0.58C per cycle and resulting in a 108C span, and extension at 728C for 30 sec. Final extension was a single cycle of 728C for 5 min. The PCR product was cloned into the pGEM-T Easy Vector (Promega Corp.) and sequenced. The correctness of the cDNA sequence was confirmed against the sea bass genomic sequence and is available in the GenBank database under accession no. JQ824128. TaqMan primers and probe for scp3 were designed using Primer Express software (Applied Biosystems), and the sequences and concentrations used were as follows: scp3 301 forward, GGAGGAGGAGCTCAACAATCTG (900 nM); scp3 377 reverse, GCTTCTGGTTCTGGACCACTCT (300 nM); and scp3 324 probe, [6;FAM]TCAGACAGCAGCAAAAGATCCTGCA GC[TAMRA] (50 nM), with an amplicon size of 77 bp and an efficiency of 0.96. Data were captured and analyzed by the iCycler iQ software (version 3.0.6070). For each experimental sample, the amount of gene transcripts was determined from the appropriate standard curve. Data were normalized using the following formula [24] : individual value within a group/(mean value within a group/mean value of control group), with the CONTROL group at Day 7 chosen as the control group. This allowed the use of an internal control that took into account loading errors and RT efficiency. Data are presented as relative mRNA levels, normalized to 18s rRNA.
Testis Histology and Immunocytochemical Staining
The fixed gonads were dehydrated in a 70%-96% ethanol series. The gonads fixed in 4% formaldehyde and 1% glutaraldehyde [20] were embedded in glycol methacrylate resin (Technovit 7100; Heraeus Kulzer). Sections (thickness, 4 lm) were stained with methylene blue, azure II, and basic fuchsin [25] to analyze the reproductive stage of each individual fish and other histological features. The gonads fixed in 4% paraformaldehyde and 10% picric acid were embedded in paraffin (Paraplast Plus; Thermo Electron) and sectioned (thickness, 5 lm). Sections were dewaxed and rehydrated to perform indirect immunocytochemical detection of BrdU incorporation, following a protocol modified from that described by Chaves-Pozo et al. [26] . Sections were incubated in peroxidase-quenching solution (H 2 O 2 [Merck] in methanol [Panreac], 1:9) for 40 min. They were then rinsed in Coon buffer (0.01 M sodium diethylbarbiturate and 0.1 M NaCl [pH 7.4]) and in Coon buffer containing 0.01% bovine serum albumin (BSA) and 2% Triton X-100 (CBT). After 30 min of incubation in 1% periodic acid at 608C, nonspecific reactions were blocked with 5% BSA (Sigma) in PBS (pH 7.4) for 20 min. Afterward, they were incubated with 1:500 anti-BrdU monoclonal antibody (Caltag Laboratories) in CBT for 2 h at room temperature in a humid chamber. Sections were washed twice in CBT and incubated with 1:100 peroxidase-conjugated rabbit anti-mouse immunoglobulin G (Sigma) in CBT for 1 h at room temperature. Next, the sections were washed in CBT and in 0.05 M Tris-HCl buffer (pH 7.6) for 5 min each. The peroxidase activity was revealed by incubation with 0.05% 3,3 0 -diaminobenzidine tetrahydrochloride (Sigma) in Tris-HCl buffer (pH 7.6) containing 0.05% H 2 O 2 for approximately 5 min at room temperature. The sections were counterstained with Mayer hematoxylin. Sections treated with the same procedure but without primary antibody served as negative control.
Histological Evaluations
To determine the number of proliferative and germinal cells, 10 animals per group and the sampling time were studied. Thirty optical areas at 1003 magnification were evaluated per fish. The areas measured were randomly distributed to cover the entire testis section. Germ cells were characterized and classified as reported in previous studies (modified from [27] ). Based on their morphology and the distribution of the heterochromatin, the germinal cell types were classified as early type A spermatogonia (StgA), late type A spermatogonia (StgA 1 ), and type B spermatogonia (StgB). StgA exhibit the largest size, with a diameter of 12.6 6 0.2 lm, and show a high cytoplasm:nucleus ratio. They have a round shape, with a large, spherical central nucleus, and dense heterochromatin around the nuclear membrane. StgA 1 are smaller in size than StgA (diameter, 9 6 0.08 lm) but have similar morphology, with heterochromatin at the nuclear membrane level, and also have a euchromatin nucleus. The different generations of StgB (diameter, 6.8 6 0.06 to 3.96 6 0.05 lm) are grouped into their corresponding cysts. Cysts increase in size as spermatogenesis progresses, whereas nuclear size and density of the cell and the cytoplasm:nucleus ratio decrease. Cysts of spermatocytes I in the leptonema-zygonema (diameter, 4.33 6 0.4 lm), paquinema (diameter, 4.18 6 0.03), and diplonema (diameter, 3.91 6 0.03 lm) phases as well as spermatocytes II (diameter, 3.28 6 0.03 lm) and spermatids were also present but not recorded. The number of proliferative Sertoli cells was also counted at Day 15 after the first injection.
Calculations and Statistics
The number of germ cells was estimated as the percentage of a particular cell type with respect to the total number counted in the area being considered. Percentage data were arcsin transformed before being used for two-way ANOVA and Holm-Sidak test analysis. Proliferation was calculated as the mean number of proliferative cells in 30 optical fields at 1003 magnification. Data are presented as the mean 6 SEM. Proliferative Sertoli cells (BrdUpositive [BrdU þ ]) were analyzed by one-way ANOVA followed by StudentNewman-Keuls test, with significance levels of P , 0.001. Controls of proliferative germ cells (BrdU þ ) were analyzed by one-way ANOVA and joined after considering that nonsignificant differences exist between them. Joined data from controls were compared with their respective experimental treatments by using a nonparametric Mann-Whitney rank sum test, with significance levels of P , 0.05. Plasma levels of Fsh and 11-KT and gene expression levels of lhr, amh, fshr, and scp3 are presented as the mean 6 SEM. Data were analyzed after logarithmic transformation by a two-way ANOVA followed by an all pair-wise multiple comparison procedure (Holm-Sidak method). Differences were accepted as statistically significant at P , 0.05. Data are presented as the mean 6 SEM. All the analyses were conducted using the statistical software Sigma Stat (version 3.0; Systat Software, Inc.).
RESULTS
Plasma Levels of Fsh and 11-KT
The intramuscular injection of scFsh resulted in a significant increase of plasma Fsh (Fig. 1) . Three days after the first injection, Fsh levels were almost 4-fold those of the control groups, remaining significantly higher until Day 7 and returning to control values 15 days after the first injection. Plasma Fsh levels of pscFSH-treated fish increased steadily from Day 0 to peak 15 days after the first injection. At Day 23, Fsh levels were still significantly higher than those of CONTROL and pcDNA3 groups. No significant changes in plasma Fsh levels were observed in CONTROL, pcDNA3, or CHO groups throughout the experiment.
To determine the effect of increased circulating Fsh on androgen steroid production, 11-KT plasma levels were measured. The scFSH-treated group showed a peak as early as Day 3 (Fig. 2) , which was significantly different from the ) using a cell-based bioassay and are presented as a proportion of the basal levels. The mean RLU of five animals sampled at Day 0 was considered to be the basal level and set as 1. Different letters denote significant differences between treatments for the same sampling point, and asterisks (*) indicate significant differences with respect to Days 3 and 7 (P , 0.05, Holm-Sidak method). Arrows indicate days when injections were administered. Data represent the mean 6 SEM of each group and sampling point.
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values of the other experimental and control groups. Seven days after the first injection, 11-KT levels declined but were still significantly higher than those of Day 0 and the control groups. Plasma 11-KT levels in the pscFSH group steadily increased from Day 3, peaking significantly on Days 7 and 15 compared to the control groups. Twenty-three days after the first injection, no differences could be observed between treatments. CHO, pcDNA3, and CONTROL groups exhibited basal levels of 11-KT throughout the experiment.
In Vivo Effects of Recombinant Fsh on Spermatogenesis
To evaluate the effects of recombinant Fsh on spermatogenesis, the number of StgA, StgA l , and StgB spermatogonia were recorded (Fig. 3) . Only StgA and StgA l were observed at the initial point (Fig. 3, inset) . At Day 7, no statistical differences in the percentage of StgA and StgA l were observed among groups (Fig. 3, A and B) . Only StgA and StgA l were observed in the control groups during the experimental period, with the exception of the CONTROL group at Day 15, where a small percentage of StgB generation could be observed (Fig. 3 , A-C). Type StgA decreased significantly on the following sampling days in both the pscFSH and scFSH groups. The percentage of StgA in the scFSH group at Day 15 and in the pscFSH group at Days 15 and 23 was significantly lower than the values observed at the initial point or in the control groups (Fig. 3, A and inset) . In the pscFSH group, StgA 1 increased steadily from Day 7 to a maximum on Day 23, which was significantly different compared to the control groups (Fig.  3B) . The scFSH group also exhibited a minor and gradual increase in StgA 1 until Day 15, but this was not significantly different from the control groups (Fig. 3B) . Seven days after the first injection, a low percentage of StgB was observed in the scFSH group (Fig. 3C) . The percentage of StgB was significantly different at Day 15 in the scFSH group and at Days 15 and 23 in the pscFSH group compared to their respective controls (Fig. 3C) . In Fsh-treated groups, more developed stages, such as StgB at Day 15 ( Fig. 4B) and cysts of spermatocytes I and II and spermatids at Day 23 (Fig. 4D), were observed, whereas only StgA and StgA 1 were present in the control groups (Fig. 4, A and C) .
The effects of Fsh treatments on germinal cell proliferation were evaluated by measuring BrdU incorporation (Fig. 5) . Both FSH treatments generated a significant increment in the proliferation of germ cells. The percentage of BrdU þ StgA, StgA 1 , and StgB was significantly increased after the treatment with pscFSH. In the scFSH group, the proliferative number of StgA and StgB was also significant. No changes in BrdU þ cells were observed in the CHO and pcDNA3 groups. Both treatments caused a significant increase in the number of proliferating Sertoli cells recorded 15 days after treatment.
Effect of Fsh on Expression of Genes Involved in Spermatogenesis
We first isolated a 570-bp cDNA fragment from the scp3 gene. BLAST (Basic Local Alignment Search Tool) searches of the GenBank databases confirmed the identity of this cDNA as corresponding to sea bass scp3. Scp3 is a component of the axial/lateral synaptonemal complex expressed in the spermatocytes [28] , therefore serving as a marker of these cell types.
To assess quantitative changes in the expression of fshr, lhr, amh, and scp3, a real-time PCR was performed (Fig. 6) . Expression of fshr (Fig. 6A) was stable in the CONTROL group during the experiment. In scFSH animals and their corresponding CHO controls, the expression of fshr decreased at Day 15 with respect to the other groups but was not different from the initial point. The highest levels of fshr expression were observed in the pscFSH group. In these animals, the expression of this gene significantly increased from Day 7 onward compared to the initial point, reaching maximum values at Day 23. The mRNA levels of lhr (Fig. 6B ) increased when gonadal recrudescence was morphologically evident in FSH-treated groups. Fifteen days after the first injection, lhr mRNA levels of fish receiving pscFsh increased significantly compared to control groups and the initial point (Day 0). These significant differences were maintained until Day 23. In the scFSH group, lhr mRNA levels increased as well, although no significant differences were observed on Day 7 or 15 compared to Day 0 and the control groups. No significant changes were observed in the CONTROL, pcDNA3, and CHO groups throughout the experiment.
Anti-Müllerian hormone gene expression was dramatically suppressed 7 days after treatment with pscFSH (Fig. 6C) . The observed expression levels were significantly lower than those of other groups or sampling points. At Day 15, amh mRNA levels in the pscFSH group were similar to those of the control groups, but at Day 23, amh expression was again significantly lower than in its own control. The down-regulation of amh expression in the scFSH group was also significantly different from the CHO control group at Day 7, remaining low until Day 15.
No changes were found in scp3 expression throughout the experimental period in the pcDNA3, CONTROL, CHO, and scFSH groups. However, the pscFSH group exhibited a slight, albeit nonsignificant, increase at Day 15, significantly peaking on Day 23 compared to the control groups and its own basal levels (Fig. 6D) .
DISCUSSION
In a previous study [17] , we introduced somatic gene transfer as a methodology to induce spermiogenesis in sea bass through extrapituitary production of Lh. Here, we have applied this approach, together with the injection of recombinant scFsh, FIG. 2 . Plasma 11-KT levels (ng/ml). Different letters indicate significant differences among groups at the same sample point, asterisks (*) indicate significant differences with respect to Day 0, and number signs (#) indicate significant differences with respect to Day 3 (P , 0.05, HolmSidak method). Data represent the mean 6 SEM of each group and sampling point.
MAZÓ N ET AL.
to determine whether the action of Fsh could trigger spermatogenesis in prepubertal male sea bass.
Injections of scFSH and pscFSH clearly increased plasmatic levels of Fsh, regardless of the administration system used, but with different performance. The scFSH generated an acute response followed by a fast clearance of the hormone from the bloodstream, whereas the increase attained by pscFSH was progressive and longer in duration. This different behavior also generated different consequences, with a spiky increment in 11-KT levels detected in the scFSH group whereas a smooth increase was observed in pscFSH animals. The increase in 11-KT levels indicates that in male sea bass, Fsh-mediated steroidogenesis stimulates early spermatogenesis, as suggested by Moles et al. [29] .
Recently, in Japanese eels, African catfish, zebrafish, and Senegalese sole, Fshr has been detected in Sertoli cells and in Leydig cells [2, 3, 8, 30] . Thus, our results suggest that in sea bass, Fsh may act on the Leydig cells, probably triggering androgen production and release. It has been speculated that in fish [31] , elevated plasma levels of Fsh at the onset of spermatogonial proliferation could be related to proliferation of Sertoli cells, whose numbers increase in association with the . Uppercase letters denote significant differences between treatments at the same sampling time, lowercase letters indicate significant differences throughout the experiment in the same group, and asterisks (*) signify statistical differences from other experimental groups at each sampling point (P , 0.05, Tukey test). Inset represents the percentage of StgA and StgA 1 at the initial point of the experiment. Data represent the mean 6 SEM (n ¼ 10 fish/sampling point).
Fsh TRIGGERS TESTICULAR RECRUDESCENCE IN SEA BASS mitotic expansion of spermatogonial cysts [32] . By using the BrdU immunocytochemical technique, we have recorded a significant increase of proliferating Sertoli cells after Fsh treatment. Injections of both scFSH and pscFSH also increased the number of StgA, StgB, and cysts of spermatocytes and spermatids, showing that the profile of proliferative cells in the experimental groups was similar to that of plasma Fsh levels. On the other hand, control groups remained quiescent, showing only StgA and StgA 1 . These results strongly support in sea bass the relation between Fsh and proliferation of Sertoli and germ cells as suggested in rainbow trout [33] and in unilaterally gonadectomized African catfish [34] and, thus, confirm that Fsh is one of the early signals to proceed with spermatogenesis. Moreover, sea bass transcripts of scp3, a specific marker of spermatocytes in medaka [35] , rainbow trout [28] , and zebrafish [36] , clearly increased in the pscFSH-treated group 23 days after the first injection, confirming their entry into meiosis and reinforcing the role of Fsh in the onset of spermatogenesis. To the contrary, in the case of the scFSH group, no significant differences were observed 15 days after the first injection. It may be that the levels of Fsh attained are high enough to promote spermatogonia proliferation but not sufficient to support meiosis. The proliferative role of Fsh has also been described in other vertebrate species. In gonadotropin-deficient hpg mice [37, 38] , treatment with Fsh increased the number of spermatogonia and spermatocytes. In chicken embryos, Mendez et al. [39, 40] also detected increases in somatic and germ cell proliferation in the gonads after exposure to human FSH. Similar results were reported by Allan et al. [1] in LH-deficient hypogonadal mice, where a complete Sertoli cell proliferation was accomplished solely by FSH activity. However, the proliferative effect of Fsh alone is a controversial issue, and several studies suggest its interaction with other factors. Indeed, some results have shown that Fsh is not strictly required, most likely being replaced by androgens [4, 41, 42] . In a previous work with Japanese eels, Ohta et al. [8] demonstrated that Fsh stimulates spermatogenesis by triggering the production of 11-KT. In fact, the presence of the 3b-hsd (hydroxysteroid dehydrogenase)-inhibitor trilostane reduced the secretion of 11-KT and, consequently, the progression of spermatogenesis was inhibited. Similarly, in zebrafish, Fsh provoked both the stimulation of steroidogenic enzyme gene expression in Leydig cells and the release of 11-KT, responsible in turn for the progression of spermatogenesis [13] . In both cases, the presence of fshr has been confirmed in Leydig cells [8, 30] ; therefore, the Fsh-activated pathway to promote spermatogenesis would very likely include the activation of Leydig cells to synthesize 11-KT. Hence, the presence of both hormones could provoke the proliferation of Sertoli cells and their associated germinal cells.
It is generally considered that fshr in fish is mainly expressed in Sertoli cells, and fshr transcripts increase in sea bass during testicular growth [21] , probably due in part to the proliferation of Sertoli cells. As spermatogenesis progresses, an expansion of cyst volume, a dilution of Sertoli cell number, and therefore, a decrease in fshr transcripts occur [32] . In the present study, no clear pattern of expression was found for this gene, with a significant reduction in the scFSH group becoming evident at Day 15 whereas the pscFSH group exhibited a significant increase. This result is difficult to explain because of the scarce amount of information available on fshr transcriptional regulation. Few arguments remain over the ability of Fsh to regulate the expression of its own receptor in either fish or mammals. In rats, the results of hypophysectomization followed by Fsh injection [43] suggested that Fsh plays a role in down-regulating the mRNA expression of Fshr, and in vitro experiments with rat Sertoli cells [44] confirmed a transient decrease in Fshr within 6-12 h of FSH stimulation. According to these antecedents, one could speculate that the fshr-increased expression levels observed in pscFSH group could be the consequence of the gradual increment in Fsh, as opposed to the acute increase of this hormone in the scFSH group.
In sea bass, Lh is associated with final maturation and ovulation/spermiation [15] in addition to the maximum levels of lhr testicular expression that are observed during spermiation [22] . Therefore, Fsh may have a dual role: to promote cell proliferation and steroidogenesis and to prepare the testicle for Lh activity. Odell et al. [45, 46] suggested that the attainment of testicular response to LH is progressive and the consequence of previous exposure of the immature testis to Fsh. Our results are in agreement with this assumption; in fact, increases in lhr transcript were detected 15 days after the first injections with Fsh, when germ cells in advanced stages of development were observed in the testicles of Fsh-treated animals. It is noteworthy that this increase was more evident in the pscFSH than the scFSH group, perhaps because the transcription of lhr needs a steady, rather than an acute, increase in Fsh. Pituitary expression of sea bass lhb increases during spermatogenesis, reaching its highest levels at spermiation [47] , coinciding with the plasma Lh level profile [22] . Due to the small sample size, Lh plasma levels were not estimated in the present study, so in further studies, it would be interesting to evaluate whether recombinant Fsh would be able to increase Lh synthesis, as observed with lhr transcripts.
Sertoli cells are the only somatic cells in the cyst whose population determines the number of germ cells, providing the necessary growth factors for the success of spermatogenesis [30, 31] . In fish, some information is available on the modulation of gene expression of these factors by androgens or estrogens, but the information on the regulatory role of Fsh is scarce [31] . Also called Müllerian-inhibiting factor (MIF) or Müllerian-inhibiting substance (MIS), AMH is one of those factors whose expression has to be suppressed for the onset of gonadal recrudescence to occur [14] . In mammalian males, this glycoprotein is responsible for the regression of Müllerian ducts [48, 49] . Despite the fact that teleost fish do not have a Müllerian duct, cDNAs with sequence similarity to amh have been cloned in a variety of fish, such as Japanese eel [14] , Japanese flounder [50] , zebrafish [51] , Atlantic salmon [52] , sea bass [53] , pejerrey [54] , rainbow trout [55] , and tilapia [56] . The present study shows changes in the expression profile of sea bass amh mRNA during Fsh-induced spermatogenesis. After Fsh treatment, 11-KT plasma levels increased, coinciding with a significant decrease in amh mRNA expression, which was very sharp in the pscFSH group and modest, but significant, in the scFSH group. This inhibition appeared in parallel to the increase in cell proliferation.
In vitro experiments in Japanese eels [14] and zebrafish [13] using recombinant amh suggest its ability to block spermatogenesis via the suppression of 11-KT synthesis [10] . In mammals, at the time of puberty, Amh was reported to be inhibited when testosterone concentration rose in the testis [57] , and transgenic mice knocked-out for Amh exhibited hyperplasia of the Leydig cells, highlighting the role of Amh in the control of Leydig cell differentiation and androgen biosynthesis [58] . On the other hand, in transgenic mice overexpressing Amh, the differentiation of Leydig cell Fsh TRIGGERS TESTICULAR RECRUDESCENCE IN SEA BASS precursors was blocked and the expression of steroidogenic protein mRNAs was reduced [59] [60] [61] . All these results suggest a relation between androgens and Amh expression. In fish, Miura et al. [14] proposed that the down-regulation of mis expression is caused by an increase in 11-KT levels. In zebrafish [13] , Amh has a suppressive role in the expression of steroidogenic enzyme (star and cyp17a1) genes; therefore, as in mammalian fetal testis [62] , Amh is described as a suppressor of androgen synthesis in Leydig cells. Thus, the expression of Amh has to be suppressed so that androgens increase. At the onset of spermatogenesis, Fsh activates Sertoli cell proliferation in both mammals [63] and fish [32] , which is very likely accompanied by a suppression of Amh production, because it has been shown that Amh inhibits cell growth and differentiation in mammals [64, 65] and in fish [13] . Our results suggest that a very early step in the onset of sea bass spermatogenesis would be the activation of Sertoli cells through the increase of plasma Fsh levels, leading to suppression of amh expression, which in association with Fsh would result in the stimulation of 11-KT by Leydig cells. However, further studies are needed to ascertain the direct suppression of amh expression by Fsh, via the activation of Sertoli cells, or as a consequence of its steroidogenic effect, via the activation of Leydig cells.
In summary, we demonstrate that Fsh is able to trigger the process of spermatogenesis in prepubertal male sea bass, initiating the proliferation of spermatogonia until its entry into meiosis. This activity includes the reduction of amh expression, and the readiness of the gonad for Lh activity through the upregulation of lhr expression. Finally, isolation and cloning of a gene or cDNA in an expression vector is faster, easier, and cheaper than producing the corresponding recombinant protein.
As we have demonstrated in the present study, the introduction and expression in vivo of a hormone-coding gene could be of FIG. 6 . A) Relative changes in expression of fshr. Asterisks (*) indicate significant differences from the initial point (P , 0.005). B) Relative changes in expression of lhr. Asterisks (*) indicate significant differences from Day 7 and the initial point, and number signs (#) indicate differences from the initial point (P , 0.005). C) Relative changes in expression of amh. Asterisks (*) indicate significant differences among sampling points, and number signs (#) indicate differences from Day 23 (P , 0.005). D) Relative expression of scp3. Asterisks (*) indicate significant differences from the initial point, and different letters indicate significant differences among experimental groups for the same sampling point (P , 0.005). Expression is normalized to 18s rRNA and is expressed as a proportion of the mean value of CONTROL group at Day 7. MAZÓ N ET AL. great interest and extremely useful both for research on reproductive endocrinology and as a tool to remedy reproductive dysfunctions in broodstock of aquacultured fish species.
